Purchase Order 75F40119P10354
- Not listed
- The U.S. Food and Drug Administration (FDA) awarded a $55,677.19 firm fixed-price purchase order to Biotek Instruments, Inc., a small business set-aside contract, for a multi-functional 96-well plate reader. The award was made on June 22, 2021, following a competitive small business solicitation posted on May 17, 2021, with a completion date of August 20, 2021. Biotek Instruments, a division of Agilent Technologies, Inc., will perform work at its facility in Winooski, Vermont. The 96-well...
- This federal contract award is for the purchase of a multi-mode microplate reader and associated maintenance services. The award was made by the Food and Drug Administration (FDA), a civilian agency, to Biotek Instruments, Inc., a division of Agilent Technologies, Inc. The contract is a firm-fixed price delivery order with a ceiling value of $24,876.00. It was awarded on July 25, 2013 with an ultimate completion date of August 26, 2017. The contract is not associated with a set-aside program....
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Biotek Instruments, Inc., a division of Agilent Technologies, Inc. The contract is for the procurement of a multi-mode microplate reader with automated digital microscopy capabilities for $89,950.00. The contract was awarded under the Multiple Award Schedule (MAS) program, and there was no set-aside designation. Biotek Instruments, Inc. has a history of providing specialized scientific equipment,...
- The Food and Drug Administration awarded a Delivery Order to Biotek Instruments, Inc., a division of Agilent Technologies, Inc., for a BioTek Cytation 5 Plate Reader/Cell Imager with accessories. This award, issued on September 4, 2019, with a ceiling value of $89,459.95 and ultimate completion date of September 4, 2021, was designated as a Total Small Business set-aside under the Scientific Equipment and Services GSA Schedule (FSS-66). The equipment will be delivered to Laurel, Maryland, and is...
- The U.S. government awarded a $20,930.40 purchase order to Biotek Instruments, Inc. for a multi-mode microplate reader under a Total Small Business set-aside designation. The contract was awarded on September 23, 2019, with an ultimate completion date of November 20, 2019, and will be performed in Winooski, Vermont. Biotek Instruments is a division of Agilent Technologies and specializes in providing laboratories with scientific instrumentation, software, and services for sample analysis and...
- This federal contract award is for a Dual Reagent Injector for a Multi-Mode Microplate Reader, with a total ceiling value of $8,275.00. The contract was awarded to Biotek Instruments, Inc., a division of Agilent Technologies, Inc., on September 5, 2014, with a performance period ending on September 4, 2015. The contract was set aside for small businesses and awarded as a firm-fixed-price purchase order by the Food and Drug Administration (FDA), a civilian agency. Biotek Instruments, Inc. has a...
- This federal contract award to Biotek Instruments, Inc., a division of Agilent Technologies, Inc., was issued by the Food and Drug Administration (FDA) under the General Services Administration (GSA) Scientific Equipment and Services (FSS-66) schedule. The $24,075.00 firm fixed-price delivery order is for the procurement of a SYNERGY H1M MULTIMODE MICROPLATE READER. The contract has no set-aside designation. Biotek Instruments, Inc. is an experienced provider of scientific equipment to various...
- This is a delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Biotek Instruments, Inc., a division of Agilent Technologies, Inc. The $93,928.58 firm fixed-price contract is for a plate reader system with imaging capability (Cytation 5) under the GSA Scientific Equipment and Services schedule. The contract has no set-aside designation. Biotek Instruments has a history of providing scientific equipment such as microplate readers, spectrophotometers, and...
- This federal contract award, with an ID of GS07F5363R|75F40120F80373, was issued by the Food and Drug Administration (FDA) to Biotek Instruments, Inc., a division of Agilent Technologies, Inc. The contract is for the delivery of a high-performance hybrid microplate reader, with a firm fixed price of $81,434.25 and a completion date of October 26, 2020. The contract was issued under the Multiple Award Schedule (MAS) program, a government-wide acquisition contract vehicle managed by the General...
- This federal contract award is for the procurement of a multimode plate reader. The contract, valued at $75,936.83, was awarded by the Food and Drug Administration (FDA) to Biotek Instruments, Inc., a division of Agilent Technologies, Inc. The contract is a delivery order and has a firm fixed price pricing type. The award is associated with the Multiple Award Schedule (MAS) contract vehicle. The contract does not have a set-aside designation, indicating it was awarded through full and open...
The Food and Drug Administration (FDA) awarded a firm fixed-price purchase order to Biotek Instruments, Inc. on July 9, 2019, for a multi-mode microplate reader with a ceiling value of $24,949.90. The contract, which was completed by August 8, 2019, was issued without a small business set-aside designation. Performance of the work took place in Winooski, Vermont. Biotek Instruments, Inc., a division of Agilent Technologies, Inc., is a specialized provider of laboratory instrumentation and consumables that support sample analysis and testing across the life sciences sector. Biotek has an established track record delivering scientific equipment to federal agencies, particularly within the Department of Health and Human Services, which includes the FDA, National Institutes of Health (NIH), and Centers for Disease Control and Prevention (CDC). The company's prior federal contract portfolio demonstrates expertise in providing microplate readers, washers, spectrophotometers, and related analytical instruments to support laboratory operations across multiple federal departments and agencies. This purchase order represents a continuation of Biotek's ongoing support of FDA laboratory capabilities for analytical testing and research applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.9k | 7/9/19 |